GAC0003A4 is an LXR inverse agonist that inhibits LXR transcriptional activity. GAC0003A4 also efficiently degrades LXRbeta protein. GAC0003A4 has the potential to be used in advanced pancreatic cancer and other refractory malignancies[1].
Molecular Weight:
340.42
Purity:
98.94
CAS Number:
[929492-71-7]
Formula:
C20H24N2O3
Target:
LXR
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted